Prof. Stephen Nicholls discusses the results of a study that investigated the lipid-lowering effects of triple therapy with bempedoic acid, ezetimibe and statin as a new potential strategy for treating hypercholesterolemia.
This video was recorded in response to a recent publication in Atherosclerosis by prof. Stephen Nicholls and colleagues.
Prof. Stephen Nicholls is professor of Cardiology and director of MonashHeart in Melbourne, Australia.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Om P. Ganda, MD
Addressing late-breaking data on triglycerides, fibrates and omega-3 FAs1.00 program credit
Peter Libby, MD
P. Gabriel Steg, MD
Prof. Kausik Ray, MBChB, MD, MPhil
Understanding the working mechanism of EPA
Preston Mason, PhD
Michael Miller, MD